T-bet在较低危骨髓增生异常综合征骨髓衰竭发病中的作用
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity cells in patients with myelodysplastic syndromes. | 期刊论文 | Zheng Zhang;Qi He |
2 | Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome | 期刊论文 | Zheng Zhang;Chunkang Chang |